IP Library Granted Patent US 11,506,652
Granted Patent B2
US 11,506,652 · App. 15/648,293 · Granted Nov 22, 2022

Compositions and methods of cell attachment

Inventors: Daniel Levner (Brookline, MA); Kyung JIn Jang (Andover, MA); Jacob Fraser (Somerville, MA); S. Jordan Kerns (Reading, MA); Antonio Varone (West Roxbury, MA); Dongeun Huh (Philadelphia, PA)
Assignee: EMULATE, INC.
G01N33/5032C07K2/00C07K14/78C12M23/16C12M23/20C12M25/02C12N5/0018C12N5/0068C12N5/067C12N5/0658G01N33/5014C12N2500/32C12N2521/00C12N2533/30C12N2533/50C12N2533/52C12N2533/54C12N2533/90C12N2535/10C12N2537/10G01N33/5044
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,506,652
App. No.
15/648,293
Granted
Nov 22, 2022
Kind
B2
Abstract

Compositions, devices and methods are described for improving adhesion, attachment, and/or differentiation of cells in a microfluidic device or chip. In one embodiment, one or more ECM proteins are covalently coupled to the surface of a microchannel of a microfluidic device. The microfluidic devices can be stored or used immediately for culture and/or support of living cells such as mammalian cells, and/or for simulating a function of a tissue, e.g., a liver tissue, muscle tissue, etc. Extended adhesion and viability with sustained function over time is observed.

Claims (36)

1. A method of treating a microfluidic device, comprising:

a) providing:

i) a microfluidic device comprising a microchannel comprising a plasma treated polydimethylsiloxane surface;

ii) a fluidic source comprising a fluid, wherein said fluidic source is in fluidic communication with said microchannel; and

iii) a source of ultraviolent light and an N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate heterobifunctional crosslinker having an ultraviolet light reactive portion and a chemically reactive portion;

b) exposing said ultraviolet light reactive portion of said N-sulphosuccinimidyl-6-( 4 ′-azido-2′-nitrophenylamino) hexanoate heterobifunctional crosslinker to said source thereby covalently attaching said crosslinker to said surface;

c) covalently attaching laminin with said chemically reactive portion of said crosslinker so as to create a laminin-treated surface;

d) storing said microfluidic device comprising the laminin-treated surface in a solution, wherein said storing is done at a controlled temperature below room temperature;

e) removing said microfluidic device from said storing;

f) seeding viable epithelial cells on said laminin-treated surface so as to create attached epithelial cells;

g) flowing said fluid from said fluid source through said microchannel so as to create flow conditions; and

h) culturing said attached epithelial cells under said flow conditions such that said attached epithelial cells remain attached and viable for at least 7 days.

2. The method of claim 1 , wherein said storing is done at between 2 and 10° C.

3. A method for culturing cells, comprising:

a) providing;

i) a microfluidic device comprising a microchannel comprising a membrane with a polydimethylsiloxane surface;

ii) a fluidic source comprising a fluid, wherein said fluidic source is in fluidic communication with said microchannel; and

iii) a source of ultraviolent light;

b) exposing an ultraviolet light reactive portion of an N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate crosslinker to said source thereby covalently attaching said crosslinker to said surface;

c) covalently attaching an extracellular matrix protein with a chemically reactive portion of said crosslinker so as to create a treated surface,

d) seeding viable epithelial cells on said protein so as to create attached epithelial cells;

e) flowing fluid in a parallel orientation to said membrane so as to create flowing conditions; and

f) culturing said attached epithelial cells that remain attached and viable for at least 14 days under said flow conditions.

4. The method of claim 3 , wherein said viable epithelial cells are hepatocytes.

5. A method of culturing cells, comprising:

a) providing:

i) a microfluidic device comprising a microchannel comprising a plasma treated polydimethylsiloxane surface;

ii) a fluid source comprising a fluid in fluidic communication with said microchannel; and

iii) a source of ultraviolet light and an N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate crosslinker having an ultraviolet light reactive portion and a chemically reactive portion;

b) exposing said ultraviolet light reactive portion of said N-sulphosuccinimidyl-6-(4′-azido-2′-nitrophenylamino) hexanoate crosslinker to said source thereby covalently attaching said crosslinker to said surface;

c) covalently attaching one or more extracellular matrix proteins to said chemically reactive portion of said attached crosslinker as to create a treated surface;

d) seeding viable epithelial cells on said treated surface so as to create attached epithelial cells;

e) flowing said fluid from said fluid source through said microchannel so as to create flowing conditions; and

f) culturing said attached epithelial cells that remain attached and viable under said flow conditions for at least 7 days.

6. The method of claim 5 , wherein said surface is a membrane.

7. The method of claim 5 , wherein said light reactive portion of said crosslinker is activated with an ultraviolet light in the presence of a mask.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2018
From: LEVNER, DANIEL; JANG, KYUNG JIN; FRASER, JACOB; KERNS, S. JORDAN; VARONE, ANTONIO; HUH, DONGEUN
To: EMULATE, INC.
Reel/Frame 046020/0053 →
Continuity (2)
Provisional Application 62361259 · Jul 12, 2016
Related Publication 20180024117A1 · Jan 25, 2018